2023 was a big year for CRISPR-based gene editing but challenges remain
2023 was an important year for patients with sickle cell disease. Prior to CRISPR, the only cure for the life-long Leer mas
Via:: Engadget
Recent Posts
2023 was a big year for CRISPR-based gene editing but challenges remain
